EU fines drug makers for keeping cheap medicine off market
|
November 27, 2020 12:06 AM
BRUSSELS (AP) — The European Union has fined two pharmaceutical companies for colluding to keep a cheap alternative to a sleep disorder medicine off the market for their profit and at the expense of patients.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
